Answers are grounded in this paper and cite their sources.
CGM technologies significantly improve glycemic control in adults with type 1 diabetes, with greater benefits for those with higher baseline HbA1c. Advanced systems demonstrate progressively greater improvements, with automated closed-loop systems showing the strongest evidence of effectiveness. These findings support broader implementation of CGM technologies, with selection tailored to individual patient needs.
No takes yet. Share an insight, caveat, or question.
Alfadli et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: